Birchview Capital as of March 31, 2017
Portfolio Holdings for Birchview Capital
Birchview Capital holds 41 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 53.1 | $95M | 767k | 124.43 | |
| Accelr8 Technology | 29.4 | $53M | 2.2M | 24.20 | |
| Vermillion | 3.1 | $5.6M | 2.8M | 2.05 | |
| EQT Corporation (EQT) | 1.4 | $2.6M | 42k | 61.11 | |
| Biolase Technology | 1.0 | $1.7M | 1.3M | 1.35 | |
| Encana Corp | 0.9 | $1.5M | 132k | 11.71 | |
| Masimo Corporation (MASI) | 0.8 | $1.4M | 15k | 93.27 | |
| Tesaro | 0.8 | $1.4M | 9.0k | 153.89 | |
| Contrafect | 0.7 | $1.3M | 725k | 1.80 | |
| Neurocrine Biosciences (NBIX) | 0.6 | $1.1M | 25k | 43.29 | |
| Oxford Immunotec Global | 0.6 | $1.0M | 67k | 15.50 | |
| Merck & Co (MRK) | 0.5 | $953k | 15k | 63.53 | |
| Wright Medical | 0.5 | $934k | 30k | 31.13 | |
| Quidel Corporation | 0.5 | $882k | 39k | 22.63 | |
| Veracyte (VCYT) | 0.5 | $870k | 95k | 9.18 | |
| Yield10 Bioscience | 0.5 | $815k | 2.3M | 0.36 | |
| Vanda Pharmaceuticals (VNDA) | 0.4 | $756k | 54k | 14.00 | |
| NxStage Medical | 0.4 | $757k | 28k | 26.84 | |
| Workhorse Group Inc ordinary shares (WKHS) | 0.4 | $684k | 260k | 2.63 | |
| Corcept Therapeutics Incorporated (CORT) | 0.4 | $658k | 60k | 10.97 | |
| Clovis Oncology | 0.3 | $637k | 10k | 63.70 | |
| Pioneer Natural Resources (PXD) | 0.3 | $559k | 3.0k | 186.33 | |
| Sientra | 0.3 | $533k | 63k | 8.42 | |
| Cabot Oil & Gas Corporation (CTRA) | 0.3 | $502k | 21k | 23.90 | |
| Quotient | 0.2 | $407k | 58k | 6.99 | |
| Sito Mobile (STTO) | 0.2 | $360k | 140k | 2.57 | |
| Celgene Corp right 12/31/2011 | 0.2 | $315k | 292k | 1.08 | |
| Oncomed Pharmaceuticals | 0.2 | $319k | 35k | 9.20 | |
| Alder Biopharmaceuticals | 0.2 | $315k | 15k | 20.79 | |
| Advaxis | 0.2 | $291k | 36k | 8.17 | |
| Xencor (XNCR) | 0.2 | $294k | 12k | 23.90 | |
| Advanced Accelerat spon ads each rep 2 ord | 0.2 | $279k | 7.0k | 39.86 | |
| Biogen Idec (BIIB) | 0.1 | $273k | 1.0k | 273.00 | |
| Genocea Biosciences | 0.1 | $238k | 39k | 6.10 | |
| Paratek Pharmaceuticals | 0.1 | $215k | 11k | 19.28 | |
| Accuray Incorporated (ARAY) | 0.1 | $191k | 40k | 4.74 | |
| Opko Health (OPK) | 0.1 | $193k | 24k | 7.99 | |
| Roka Bioscience | 0.1 | $166k | 47k | 3.55 | |
| Pacific Biosciences of California (PACB) | 0.1 | $140k | 27k | 5.19 | |
| Merrimack Pharmaceuticals In | 0.1 | $136k | 44k | 3.09 | |
| Aevi Genomic | 0.1 | $126k | 68k | 1.85 |
